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Abstract
Background: Because ribosomes are ubiquitously required for protein production, it was long assumed that any
inherited defect in ribosome manufacture would be embryonically lethal. However, several human congenital
diseases have been found to be associated with mutations in ribosome biogenesis factors. Surprisingly, despite the
global requirement for ribosomes, these “ribosomopathies” are characterized by distinct and tissue specific
phenotypes. The reasons for such tissue proclivity in ribosomopathies remain mysterious but may include
differential expression of ribosome biogenesis factors in distinct tissues.
Methods: Here we use in situ hybridization of labeled antisense mRNA probes and ultra high temporal resolution
RNA-Seq data to examine and compare expression of 13 disease associated ribosome biogenesis factors at six key
stages in Xenopus tropicalis development.
Results: Rather than being ubiquitously expressed during development, mRNAs of all examined ribosome
biogenesis factors were highly enriched in specific tissues, including the cranial neural crest and ventral blood
islands. Interestingly, expression of ribosome biogenesis factors demonstrates clear differences in timing, transcript
number and tissue localization.
Conclusion: Ribosome biogenesis factor expression is more spatiotemporally regulated during embryonic
development than previously expected and correlates closely with many of the common ribosomopathy
phenotypes. Our findings provide information on the dynamic use of ribosome production machinery components
during development and advance our understanding of their roles in disease.
Keywords: Ribosome, Development, Diamond-Blackfan anemia, North American Childhood Cirrhosis, TCOF1, RPL,
RPS, UTP, Ribosome biogenesis, Ribosomopathy, Xenopus
Background
Ribosomes translate genetically encoded information
into proteins. Their production is a ubiquitous, carefully
regulated, and energetically expensive cellular process. It
is so essential to life that it alone accounts for over 60 %
of total transcription in eukaryotic cells [1, 2]. While it
was long assumed that any defect in this fundamental
process would be incompatible with life, mutations af-
fecting ribosome production have now been identified in
several human congenital disorders (ribosomopathies)
and in animal models [3–15]. Despite all arising from
abnormalities in the ubiquitous process of ribosome bio-
genesis, these diseases exhibit unexpectedly unique phe-
notypes (Table 1) [1, 16–18]. The reason for this tissue
proclivity remains mysterious but its existence hints at a
fundamental cell type specificity in ribosome biology
during development.
Ribosome production is a complex process. Briefly
summarized, each 80S ribosome is composed of two ri-
bonucleoprotein subcomplexes. The large 60s subunit
(LSU) is composed of the 28S, 5.8S and 5S ribosomal
RNAs (rRNAs) and 46 associated ribosomal proteins
(RPL), while the small 40S subunit (SSU) contains the
18S rRNA and 33 ribosomal proteins (RPS, Fig. 1a) [1,
18]. Production of these subunits begins in the nucleolus
with the transcription of the polycistronic pre-ribosomal
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RNA (rRNA) by RNA polymerase I (RNAPI). This large
precursor rRNA then undergoes numerous sequential
cleavages, modifications and foldings to ultimately pro-
duce the mature 18S rRNA, 5.8S and 28S rRNAs. The
5S rRNA is transcribed separately by RNA polymerase
III (Fig. 1a). Correct transcription and processing of the
rRNAs and their assembly into the ribosomal subcom-
plexes requires the concerted action of all three RNA
polymerases, 75 small nucleolar RNAs (snoRNAs), and
over 200 ribosome biogenesis factors [1, 16, 19–21].
Each of these biogenesis factors must also be transcribed
by RNA polymerase II, translated by cytoplasmic ribo-
somes and localized correctly to carry out its function in
the nucleolus, nucleus or cytoplasm (Fig. 1a) [1, 16, 18].
A number of human diseases are now associated with
defects in ribosome production (Table 1). For example,
lesions in at least 15 different ribosomal proteins (RP)
underlie Diamond-Blackfan anemia (DBA, OMIM#
105650, RPL and RPS mutations) [22–31]. These anom-
alies affect pre-rRNA processing and assembly of the
SSU or LSU, and typically result in bone marrow failure.
Craniofacial, growth and limb defects are also commonly
present in patients [16, 22, 25]. Mutations in the ribo-
some biogenesis factor hUTP4 (formerly called Cirhin),
cause North American Indian Childhood Cirrhosis
(NAIC, OMIM# 604901, UTP4 mutations), a form of
biliary cirrhosis [32, 33]. Without a liver transplant in
childhood, this condition is fatal. In Shwachman-
Bodian-Diamond syndrome (SBDS, OMIM# 260400),
patients present with pancreatic failure, bone marrow
defects and skeletal abnormalities caused by mutations
in the SBDS protein that impair maturation of the large
ribosomal subunit [34–36]. Treacher-Collins syndrome
(TCS, OMIM# 154500, typically TCOF1 mutations) is
characterized primarily by craniofacial defects [1, 3, 5,
16, 18, 37–39]. Other major ribosomopathies include
Chromosome 5q- syndrome (5q, OMIM# 153550, ac-
quired RPS14 mutations, macrocytic anemia) [1, 16, 40],
Alopecia, Neurological and Endocrinopathy syn-
drome (ANE, OMIM# 612079, RBM28 mutations) [41],
and isolated congenital asplenia (ICA, OMIM#
271400, RPSA mutations), that specifically impairs
spleen development [42]. Numerous additional con-
firmed and suspected ribosomopathies exist (Table 1).
While some of the ribosomopathies have defects in com-
mon (e.g. anemia, growth retardation, craniofacial de-
fects, increased risk of cancer), these diseases are
clinically distinct and difficult to treat. Understanding
their etiology is a first step towards improving treatment
options and patient prognosis.
Why defects in the ubiquitous production of ribo-
somes lead to tissue specific phenotypes remains a fas-
cinating and clinically important question. One
possibility is that the affected tissues are simply rapidly
dividing and are thus more sensitive to reduced ribo-
some numbers. However, this does not account for the
Table 1 Diseases of Ribosome Biogenesis
Ribosomopathy Proteins Function Phenotype
Diamond-Blackfan Anemia RSP7, RPS10, RPS17, RPS19, RPS24,
RPS26, RPS27, RPS29
Processing of 18S rRNA anemia, bone marrow failure,
craniofacial and limb defects,
cancer predisposition
RPL5, RPL11, RPL15, RPL26, RPL27,
RPL31, RPL35A
Processing LSSu rRNA anemia, bone marrow failure,
craniofacial and limb defects,
cancer predisposition
5q-Syndrome RPS14 18S rRNA processing anemia, bone marrow failure,
myelodysplastic syndrome,
cancer predisposition
Treacher-Collins Syndrome TCOF1 rDNA transcription & 18S
processing
Craniofacial
North American Indian Childhood
Cirrhosis
UTP4 (formerly Cirhin) 18S rRNA maturation Billary cirrhosis
Bowen-Conradi Syndrome EMG1 Maturation of SSU Growth retardation, psychomotor
delay, skeletal
Isolated Congenital Asplenia RPSA Maturation of SSU Spleen loss
X-linked subtype of dyskeratosis
congenita
Dyskerin Linked to H/ACA snoRNA
and TERC
Variable, reticulated hyperpigmentation
of skin, nail dystrophy, leukoplakia,
bone marrow defects
Shwachman-Diamond Syndrome SBDS Maturation and export of
LSU
Growth retardation, exocrine pancrease




RBM28 Maturation of LSU Growth retardation, impaired motor
skills, mental retardation, hair loss, skeletal
and skin abnormalities, adrenal defect.
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non-overlapping phenotypes observed in these syn-
dromes, or explain why some highly active populations
appear unaffected. Other proposed mechanisms include
1) selective translation of mRNAs with internal ribosome
entry sites and 2) extra ribosomal functions specific to
each protein [16, 43–48]. One intriguing possibility that
may explain the diverse effects of ribosomal protein ab-
normality is that ribosomes are tailored to translate spe-
cific mRNAs, or have particular properties in different
cell types. Changes in ribosomal composition and bio-
genesis may then affect these activities. In support, re-
duction of Rpl38 in mice can alter the composition of
Hox gene mRNAs translation and embryonic patterning,
without reducing overall protein synthesis [6]. Further-
more, ribosomal gene mRNA expression exhibits signifi-
cant variation across tissues [6, 46, 47, 49–51]. Such
variation may result in differential ribosome production
and activity. This idea of specialized ribosomes chal-
lenges our notion of ribosomes as monolithic entities
and may suggest a fundamental mechanism of transla-
tional regulation. However, a comprehensive spatiotem-
poral understanding of ribosomopathy associated gene
expression during development is not known, which is
essential to correlate with the tissue proclivity observed
in ribosomopathies.
As a preliminary step in examining this issue, we ana-
lyzed the expression of thirteen distinct ribosome bio-
genesis factors (rps7, 14, 17, 19, 29, rpl15, 26, 35a, 38,
tcof1, rbm28, sbds and utp4) using whole mount in situ
hybridization and ultra high temporal resolution RNA-
Seq data. Mutations in twelve of these factors are impli-
cated in six phenotypically distinct human conditions.
We found that expression of these genes is greatly up-
regulated in specific tissues during development,
Fig. 1 a Schematic of ribosome biogenesis. The rDNA is transcribed by RNA polymerase I and the resulting rRNA is processed in the nucleolus
before being incorporated into the large ribosomal subunit (LSU) or small ribosomal subunit (SSU). b Schematic of X. tropicalis embryos at
examined stages. Major anatomical features are labeled. A: anterior, P: posterior, D: dorsal, R: ventral
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particularly in the cranial neural crest (CNC) and ventral
mesoderm, and broadly correlates with common ribo-
some disease phenotypes. While the general pattern of
expression is similar for all examined genes, unexpected
differences do exist. Overall our study reveals extensive
spatiotemporal regulation of ribosome biogenesis factor
expression during embryonic development.
Methods
Xenopus embryos
X. tropicalis were maintained and cared for in our
aquatics facility, in accordance with Yale University Insti-
tutional Animal Care and Use Committee protocols.
Embryos were produced by in vitro fertilization and
raised to appropriate stages in 1/9MR + gentamycin [52].
Whole-mount in situ hybridization
Full length clones for; rbm28, TTpA003i23; rpl15, IMAGE:
7606910; rpl26, TNeu089l11; rpl35a, TNeu023b09; rpl38,
TNeu074p13; rps7, TNeu091o12; rps14, IMAGE: 8896584;
rps17, TNeu101k22; rps19, TNeu108f02; rps29,
TGas050g16; sbds, TGas062n22; tcof1 TEgg112k11, and
upt4, TGas051c03 were obtained in pCS107 vector from
the Sanger/Wellcome Trust Xenopus tropicalis cDNA li-
braries. Digoxigenin-labeled antisense mRNA probes were
in vitro transcribed with T7 High Yield RNA Synthesis Kit
(E2040S) from New England Biolabs. Embryos were col-
lected at desired stages, fixed in MEMFA for 1–2 h at room
temperature and dehydrated into 100 % ETOH. Whole
mount in situ hybridization was performed as described
previously [4, 53]. Embryos were stained with BM Purple
and examined after equilibration in 100 % glycerol.
High temporal resolution RNA-Seq
Gene expression trajectories were compared using our
previously published RNA-seq data [54] (GEO:
GSE65785), which reports gene expression in absolute
transcripts per embryo. X. tropicalis v7.1 models as used
in [54] for rpl15, rpl26, rpl35a, rpl38, rps7, rps17, rps19
were found to be incorrect, and were corrected with ref-
erence to reads and gene models from X. tropicalis v4
assembly. Corrected gene models are available in Add-
itional file 1. Gene expression abundances in absolute
transcripts per embryo were re-quantified with improved
models as described in [54].
Results
To study expression of ribosome biogenesis factors dur-
ing embryonic development, we examined six key devel-
opmental stages: 3, 10, 15, 20–22, 28–30, and 36–40
(Fig. 1b). These stages mark critical time points during
embryogenesis, including maternal RNA inheritance,
germ layer specification, morphogenesis and organogen-
esis. We examined gene expression in numerous ana-
tomical structures including the neural tube, streams of
migrating neural crest, pharyngeal arches, heart, eye,
ventral mesoderm, and pronephros (described in Fig. 1b).
In situ hybridizations using digoxigenin labeled sense
mRNA probes for each gene were carried out as controls
(Additional file 2).
Expression of ribosome biogenesis factors
We began by examining the expression patterns of four
ribosome biogenesis factors that have previously been
implicated in phenotypically distinct human malforma-
tions, tcof1, rbm28, sbds, and utp4.
With the exception of tcof1, signal for each factor was
weakly detected at the 4-cell stage and in the animal
pole surrounding the blastopore at stage 10. Interest-
ingly, tcof1 expression appeared much more robust in
these tissues (Fig. 2a). At stage 16 expression of all genes
was strongly associated with the anterior neural plate
and neural fold borders where CNC form. At stage 22
transcripts were robustly detected in the migrating CNC
and the posterior region of the neural tube. Expression
was typically much weaker or absent in the intermediate
regions of the neural tube. Uniquely, utp4 transcripts
were detected in the ventral mesoderm at this stage
(Fig. 2a).
At stage 28 all four ribosome biogenesis factors were
similarly expressed in the CNC populated craniofacial
regions as well as the developing eye and otic placode
(Fig. 2b). Interestingly, expression within the developing
brain appeared strong and spatially restricted at the mid
– hindbrain border (a crucial signaling center) and in
discreet regions of the forebrain. Expression of rbm28,
tcof1 and utp4 also appeared enriched in the posterior
neural tube and tail bud, while expression of sbds was
more uniform along the length of the neural tube. tcof1
and rbm28 were also detected in hypaxial muscle and
the ventral mesoderm/blood island region (Fig. 2b). Cor-
onal sections through the craniofacial region revealed
(See figure on previous page.)
Fig. 2 Expression of disease-linked ribosome biogenesis factors in X. tropicalis embryos. a Expression of all four genes was detected in the 4-cell
and gastrulating embryo. Signal was strongly detected in the neural folds at stage 16 and in the migrating neural crest at stage 22. b At later
stages expression of all factors was detected in the facial primordia and developing brain. Note the restricted expression at the mid–hindbrain
border and forebrain. Expression was also typically detected in ventral mesoderm and hypaxial muscle precursor cells. utp4 mRNA was strongly
detected at the site of the future liver. c Red lines labeled a*, b* and c* in diagrams of stage 10 and 28 embryos represent the planes of section
shown in a and b
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strong and specific expression of each gene within the
mandibular, hyoid and branchial CNC populated
pharyngeal arches, while transverse sections through the
trunk confirmed expression in the neural tube (Fig. 2b).
At stage 36–40 this precise spatial regulation of expres-
sion was largely maintained. tcof1 and rbm28 were
expressed strongly in the CNC populated facial regions,
the developing ear, and strongly in the mid-hindbrain
and fore-midbrain boundaries. Their expression ap-
peared significantly less robust, or absent, in other re-
gions of the brain and neural tube. Interestingly, sbds
was detected much more broadly throughout the cranio-
facial region and neural tube at these stages while utp4
expression was greatly enriched specifically in the head.
While all assayed genes were detected diffusely in the re-
gion of heart and liver at stage 36, utp4 expression was
observed in this region at stage 28 and was notably
broad and robust here at stage 36–40 (Fig. 2b).
Expression of rps genes: rps7, 14, 17, 19, 29
We next examined the expression of several key RPS
genes. RPS7, 17, 19 and 29 are all associated with
Diamond-Blackfan anemia, which is principally charac-
terized by defects in bone marrow, craniofacial and limb
development. RPS14 mutations underlie 5q- syndrome,
an acquired ribosomopathy that is characterized by mac-
rocytic anemia and cancer predisposition.
At the 4-cell stage we detected variable amounts of
maternal rps transcripts. rps7 revealed little or no signal
in the animal pole, while rps14 signal was relatively
strong. rps17, 19 and 29 each displayed intermediate
levels of staining (Fig. 3a). At stage 10, shortly after the
maternal to zygotic transition, all RPS genes examined
exhibited comparably diffuse signal around the blasto-
pore of whole mount gastrulating embryos. Expression
of rps7 appeared more robust in the animal tissues when
embryos were sectioned (Fig. 3a). At stage 15 expression
of all genes was detected within the neural folds and
border regions where the CNC are being induced. At
stages 18–22 the examined rps genes were expressed in
the neural tube, developing brain and migrating neural
crest. Interestingly, rps7 transcripts were more highly de-
tected in the somites when compared to other rps
mRNAs (Fig. 3a).
At stage 28, all were robustly expressed throughout the
craniofacial regions, including the CNC populated
mandibular, hyoid, anterior and posterior pharyngeal
arches, forebrain, midbrain, hindbrain, otic and optic pla-
codes. Interestingly, we detected signal in the dorso-lateral
plate mesodermal region where the pronephic tubule and
hypaxial muscle will form in rps14, 17, 19 and 29, but this
signal was not observed in rps7 (Fig. 3b). However, rps7
expression in the somites continued to be much more de-
fined than that of other RPS genes. Robust expression of
rps17, 19 and 29 was also detected in the heart and ventral
mesoderm/blood island regions at this stage suggesting a
possible role in hematopoiesis, while expression of rps7
was not evident in the ventral blood islands, and rps14
was not detected in the heart or blood islands (Fig. 3b). By
stages 36–40 rps17, 19 and 29 were ubiquitously detected
throughout the embryo, while rps7 and 14 were absent
from ventral regions.
Expression of rpl genes: rpl15, 26, 35a, and 38
Mutations in numerous RPL genes have also been impli-
cated in DBA. Here we examine the developmental ex-
pression pattern of three such rpl genes (15, 26 & 35a).
We also compare expression of rpl38, which has not yet
been identified in human disease but heterozygous loss
in mice results in anemia and skeletal malformations [6].
Expression of all assayed rpl genes was weak or absent
at 4-cells. rpl15 and rpl26 expression was also un-
detected at gastrulation stages, while rpl35a and rpl38
were clearly evident in the animal pole (Fig. 4a). Interest-
ingly, while rpl26, rpl35a and rpl38 transcripts were
strongly detected in the neural folds at stage 16, rpl15
remained absent. At stage 22 rpl26, rpl35a and rpl38
mRNA were detected in the developing brain, neural
tube and migrating neural crest (Fig. 4a). rpl38 also ex-
hibited very defined expression domains within the so-
mites. Expression of rpl15 continued to be very low or
absent at this stage.
By stage 28, expression of all four rpl genes was strongly
associated with the developing brain, neural tube, all
pharyngeal arches, otic and optic placodes, developing heart
field and ventral mesoderm/blood islands. This pattern was
broadly maintained at stage 36–40. Expression of rpl26 and
rpl38 appeared ubiquitous at these stages (Fig. 4b).
High temporal resolution RNA-seq analysis
We previously created a genome-wide RNA-seq dataset
with ultra high temporal resolution [54]. This dataset
(See figure on previous page.)
Fig. 3 rps genes are dynamically expressed in development. a Expression of all five rps genes examined was observed in the stage 10 gastrula,
stage 16 neural folds, and migrating CNC at stage 20–22. b Each gene was widely detected in the developing head at later stages (28–40),
including all the pharyngeal arches, brain, eyes and ears. rps17, 19 and 29 were also robustly detected in the ventral mesoderm, while rps7 was
particularly defined in somites. With the exception of rps7, transcripts of all mRNAs were detected in the dorso-lateral plate mesodermal region
where the pronephros and hypaxial muscle will form. c Red lines labeled a*, b* and c* in diagrams of stage 10 and 28 embryos represent the
planes of section shown in a and b
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allows precise measurement of absolute transcripts per
embryos, and comparison of expression dynamics for
the entire transcriptome during Xenopus development.
Here we utilized this rich resource to measure ribosome
associated gene transcript kinetics in the embryo.
Ribosomopathy associated genes displayed signifi-
cant variation in transcript numbers and expression
dynamics throughout embryogenesis. While all RP
genes examined exhibited a similar dynamic, evident
as a continuous increase in expression as the embryo
grows, there were pronounced differences in absolute
transcript numbers (Fig. 5a). Ribosome biogenesis fac-
tor genes were expressed at lower levels than rpl or
rps mRNAs and exhibited highly dynamic and regu-
lated expression profiles (Fig. 5b). This was evident
both in the number of transcripts and in the tem-
poral regulation of expression (compare sbds and
rbm28 for example). Interestingly these biogenesis fac-
tors generally exhibited three, variably pronounced,
peaks of expression during development suggesting
increased biological demand at these stages (red ar-
rows, Fig. 5b). The first peak occurs during early gas-
trulation stages as the embryo undergoes the complex
cell movements and differentiations required to correctly
establish the germ layers. The second peak occurs be-
tween stages 22–28, an extremely active developmental
window marked by cell migrations, differentiation, rapid
growth, and morphological change (Fig. 5b). Similarly, a
third expression peak was evident at stage 36–45, a time
of pronounced organogenesis and activity.
Discussion
Ribosomes are generally thought of as monolithic cellu-
lar machines, ubiquitously expressed and functionally
identically in every cell and tissue. However, an emerging
body of research suggests that this is not the case. In
particular, the diverse tissue specific phenotypes ob-
served in human ribosomopathies and animal models
point to an intriguing variation in requirements for ribo-
some biogenesis factors and/or ribosome biology during
development [1, 4, 6, 7, 16, 25, 32, 36, 42, 46, 47, 50].
Here, we examined the developmental expression pat-
terns of 13 ribosome-associated genes in Xenopus. With
the exception of rpl38, the human orthologue of each of
these has been implicated in disease. We found that
ribosome-associated genes are not ubiquitously
expressed during Xenopus development. Instead expres-
sion of components of the ribosome production machin-
ery was highly spatiotemporally regulated, suggesting
tissue specific activity.
All examined ribosome biogenesis factors were expressed
in generally similar and dynamic spatial patterns. This in-
cluded strong expression in the cranial neural crest,
pharyngeal arches arches, eye and ears. Expression was also
commonly detected within the developing brain, neural
tube and ventral blood islands (summarized in Table 2).
While overall patterns were similar, surprising differences
were noted in both location and quantity of transcripts. For
example, rps7 transcripts were strongly detected in the so-
mites at stage 22 but not in the developing kidney or
hypaxial muscle at stage 28, while rps14, 19 and 29 were
(See figure on previous page.)
Fig. 4 Expression of rpl genes. a rpl mRNA was weakly detected or absent at early stages of development but, with the exception of rpl15,
became up-regulated in the neural folds and migratory neural crest from neurula stages onwards. b At later stages expression of all four rpl genes
was evident broadly throughout the head, pharyngeal arches, neural tube and ventral mesoderm/blood islands. c Red lines labeled a*, b* and c*
in diagrams of stage 10 and 28 embryos represent the planes of section shown in a and b
Fig. 5 Dynamics of gene expression of poly(A) + mRNA in transcripts per embryo . a Plot of all examined genes. Note the relatively consistent
dynamics but variably levels of of RP gene transcription. b Expression dynamics of ribosome biogenesis factors. While variable, three pronounced
peaks in expression are evident during development (red arrows). c Expression of individual biogenesis factors
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the opposite. Even more striking was the clear restriction of
ribosome biogenesis factor expression compared to constit-
uents of the LSU and SSU (rps and rpl genes). At stage 22
these biogenesis factors (Fig. 1) were typically greatly
enriched in the anterior and posterior regions of the neural
tube while rps and rpl transcripts were more evenly distrib-
uted. Moreover, at stage 28 their expression in the head
was largely restricted to the CNC, eye, ear and mid-
hindbrain boundary compared to the much broader cranio-
facial expression of rpl and rps genes (compare Fig. 2 vs.
Figs. 3 and 4). Transcript number and expression kinetics
also varied dramatically over time, hinting at unexpected
stoichiometric relationships in ribosome production. Inter-
estingly, the rhythmic expression observed in biogenesis
factors, particularly rbm28, is similar to the dynamics of
circadian genes. This observation fits well with previous
reports that the circadian clock regulates ribosome bio-
genesis and mRNA translation [55]. These restricted and
varied expression patterns are suggestive of tissue specific
requirements and together with previous studies [6, 51,
55] suggest a greater dynamism of ribosome production
genes than generally assumed.
The expression patterns observed also correlate closely
with common ribosomopathy phenotypes. For example,
craniofacial defects and macrocytic anemia are frequent
features of ribosomopathies, particularly DBA and TCS [3,
5, 18, 22, 23, 37, 43]. We found expression of all 15 ribo-
some production genes to be strongly associated with the
CNC and developing head. The sensitivity of the CNC to
perturbations in ribosome production has been noted in
both human patients and in animal models [3–5, 7], where
it often appears to trigger a nucleolar stress response lead-
ing to increased apoptosis within the developing CNC and
other tissues [4, 5, 7, 13, 45, 56–58]. The consistent and ro-
bust expression of all 15 examined ribosome associated
genes in the CNC and head provides further evidence of a
high ribosomal requirement in these tissues and suggest
that ribosomal defects may contribute to unexplained cra-
niofacial malformations. The majority of gene transcripts
were also detected in the ventral mesoderm, in the region
of the ventral blood islands. This compartment makes a
critical contribution to the erythrocyte population in the
developing tadpole [59, 60]. While bone marrow is not yet
formed in the tadpole at the stages examined, this expres-
sion is consistent with a role in red blood cell development.
Several other genes also overlapped with their clinical phe-
notypes. For example, rbm28 expression in the developing
brain and utp4 expression at the site of the future liver cor-
relate with disease phenotype.
However, later stage embryonic expression patterns
alone do not accurately predict disease phenotype, as all
examined genes display broadly similar expression but
are associated with phenotypically distinct diseases. For
example, we detected utp4 in the craniofacial regions
similar to tcof1, rpl and rps genes. However, its mutation
in humans and knockdown in zebrafish lead specifically
to a failure in liver development [1, 8, 32]. In compari-
son tcof1 mutation is characterized by craniofacial mal-
formations, while rpl/rps mutations often produce a
broader range of abnormalities, including anemia,
Table 2 Sites of enriched ribosome biogenesis factor expression
Ribosome biogenesis factors
rbm28 sbds tcof1 utp4 rps7 rps14 rps17 rps19 rps29 rpl15 rpl26 rpl35a rpl38
Sites of enriched
expressions
4 Cell + + + + - + + + + - - - +
Gastrula + + + + + + + + + - - + +
Anterior neural folds + + + + + + + + + - + + +
Neural fold border + + + + + + + + + - + + +
Migrating neural crest + + + + + + + + + - + + +
Brain + + + + + + + + + + + + +
Specific mid/hind brain border + - + + - - - - - - - - -
Hyoid arch + + + + + + + + + + + + +
Mandibular arch + + + + + + + + + + + + +
Neural tube + + + + + + + + + + + + +
Paraxial muscle + - + - - - + + + + + - +
Eye + + + + + + + + + + + + +
Ear + + + + + + + + + + + + +
Heart/liver region + + + + + + + + + - + + +
Pronepheros - - - - - + + - - + + + +
Ventral mesoderm/blood
islands
+ - + + - - + + + + + + +
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craniofacial and growth defects [1, 3, 5, 8, 10, 14–16, 22,
23, 32, 34, 37, 43]. Expression at earlier stages of devel-
opment, or the availability of maternal derived protein,
may partially explain this apparent paradox. Interest-
ingly, our RNA-Seq and in situ data suggest relatively
high levels of maternal tcof1 transcript at early develop-
mental times relative to rps/rpl genes. Thus, there may
be sufficient Tcof1 present to meet early developmental
requirements, such as hematopoietic stem cell specifica-
tion, but not later CNC demands. This early enrichment
of tcof1 and relative paucity of rp gene expression has
also been observed in zebrafish [10, 25, 39], suggesting it
is an evolutionary conserved feature. In future studies, it
would be informative to further assay initial levels of
maternal transcript or protein and determine if this cor-
relates with the timing of phenotype.
The biological reasoning behind these restricted gene ex-
pression patterns, and their mechanistic contribution to dis-
ease remain unclear. It is possible that these tissues are
highly active and require greater numbers of ribosomes,
which in turn makes them more sensitive to ribosome bio-
genesis defects. However, it is then surprising that we do not
see expression in other active and rapidly dividing tissues at
these stages, or identical expression patterns for all the ribo-
some biogenesis factors examined. Several ribosome biogen-
esis factors and proteins have extra-ribosomal functions [16,
19, 44, 48, 61–63], or roles in selective translation of internal
ribosome entry site mRNAs [16, 43, 46, 47, 64], which may
also contribute to ribosomopathy phenotypes. “Specialized ri-
bosomes”, tailored to preferentially translate specific mRNAs,
or to have specific properties in particular environments are
another possibility [6, 16, 17, 25, 46, 47, 50]. Support for this
is found primarily in observations that ribosomal gene ex-
pression levels do vary between tissues [6, 7, 49, 51, 65, 66],
and direct evidence of a regulatory role for individual RP
proteins in selective mRNA translation and embryonic tissue
patterning [6, 16, 43, 49, 50]. Furthermore, in Dictyostelium
ribosome composition appears to shift with cell cycle [67,
68]. These findings suggest that ribosomes are not ubiqui-
tously identical machines. Our observation of differential
ribosome biogenesis factor expression during development
provides additional support for this idea.
Conclusions
While not new, the concept of specialized ribosomes is
potentially a paradigm shifting advancement in our un-
derstanding of the fundamental interactions between
ribosome biology, translation, cell cycle and embryonic
development. Such topics are the focus of ongoing in-
vestigations and promise to greatly enhance our know-
ledge of a core biological process and a severe class of
human diseases. In demonstrating the highly regulated
and varied expression patterns of ribosomopathy genes
during embryonic development, our results provide
further support for the existence of tissue specific ribo-
somal requirements or functions, which may contribute
to the startling tissue proclivity of ribosomopathies.
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